Not many dividend stocks can boast the diversification, growth opportunities, and solid balance sheet of health-care company Johnson & Johnson (NYSE: JNJ). With products ranging from consumer goods, like Band-Aids, to cutting-edge drugs for the treatment of prostate cancer, Johnson & Johnson is an attractive stock to dividend investors. In this video, from the Motley Fool's health-care show Market Checkup, analysts David Williamson and Max Macaluso discuss reasons to be bullish about Johnson & Johnson.
Source: Motley Fool
Related Articles:
- International Diversification May Be Closer than You Think
- 10 Dividend Stocks With A 10% Yield In 10 Years
- Free Cash Flow Payout vs. Dividend Payout
- 9 Dividend Stocks Trading at a Double-Digit Discount
- 6 High-Dividend, Low P/E Value Stocks
________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.